Influence of Residual Astigmatism on Visual Acuity in Patients Undergoing Cataract Surgery With Trifocal Intraocular Lens Implantation

May 11, 2020 updated by: Enrique Ordiñaga-Monreal, OD, MSc

MAIN OBJECTIVE: To assess the influence of residual astigmatism on visual acuity in the different lens foci in patients operated on for cataracts with a trifocal intraocular lens implant.

SECONDARY OBJECTIVE: To study the influence of residual astigmatism on the visual quality of the patient in the far focus and to determine if there are differences of affectation in the two study groups.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

It will be studied how small residual astigmatisms after cataract surgery degrade the visual acuity of patients in the three focal planes of trifocal IOLs. Not only VA will be studied, but also visual quality through contrast sensitivity curves.

Study Type

Observational

Enrollment (Anticipated)

48

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Barcelona, Spain, 08022
        • Recruiting
        • Clinica Oftalmológica TACIR
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The field in which it will carry out the study is a private medical centre. TACIR Ophthalmology clinic is located in the TEKNON Medical Center in the city of Barcelona. The study population will be the patients of the TACIR ophthalmology clinic who will be operated on cataracts and agree to take part in the study.

Description

Inclusion Criteria:

  • Bilateral surgery performed by the same surgeon
  • IOLs implanted IOLs FineVision (MicroF) and FineVision Toric (PodFT)
  • Patients with pre-surgery corneal astigmatism less than 2.5 D
  • Patients whose pupillary diameter in physiological position (conditions of lower photopic pupil) not over 4 mm.

Exclusion Criteria:

  • Post-surgical refractive residual astigmatisms ≧ 1.55D
  • Previous corneal or intraocular surgeries
  • Active diseases
  • Eye complications during the 3-month follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Trifocal IOL(Finevision IOL, PhysIOL)
We will divide the sample into two groups of patients depending on the IOL implanted First group: FineVision
Patients will be divided between groups based on pre-surgery corneal astigmatism. Group FineVision is made up of patients with corneal astigmatism less than 1 D. Groups FineVision Toric is made up pf patients with corneal astigmatism more than 1.25 D
Other Names:
  • FineVision IOL
  • FineVision Toric IOL
Trifocal toric IOL (Finevision Toric IOL, PhysIOL)
We will divide the sample into two groups of patients depending on the IOL implanted: Second group: FineVisionToric
Patients will be divided between groups based on pre-surgery corneal astigmatism. Group FineVision is made up of patients with corneal astigmatism less than 1 D. Groups FineVision Toric is made up pf patients with corneal astigmatism more than 1.25 D
Other Names:
  • FineVision IOL
  • FineVision Toric IOL

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Acuity
Time Frame: 3 months following cataract surgery
Visual acuity will be measured at distance, intermediate distance (67 cm) and near (40 cm). Visual acuities will be obtained with logarithmic notation
3 months following cataract surgery
Contrast Sensitivity Function (CSF)
Time Frame: 3 months following cataract surgery
Contrast sensitivity will be measured at far, intermediate distance (67 cm) and near (40 cm).
3 months following cataract surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences between groups
Time Frame: 3 months following cataract surgery
Results will be compared between groups.
3 months following cataract surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Enrique Ordiñaga-Monreal, OD, Clinica Oftalmológica TACIR

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 29, 2019

Primary Completion (Actual)

March 1, 2020

Study Completion (Anticipated)

July 1, 2021

Study Registration Dates

First Submitted

May 11, 2020

First Submitted That Met QC Criteria

May 11, 2020

First Posted (Actual)

May 14, 2020

Study Record Updates

Last Update Posted (Actual)

May 14, 2020

Last Update Submitted That Met QC Criteria

May 11, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • EC042019
  • 2019/65-OFT-CMT (Other Identifier: CEIm Grupo Hospitalario Quirónsalud-Catalunya)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Astigmatism

Clinical Trials on Kind of trifocal IOL

3
Subscribe